ArticleYonsei medical journal2014

LRIG1 enhances chemosensitivity by modulating BCL-2 expression and receptor tyrosine kinase signaling in glioma cells.

Zhentao Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.